0001225208-13-023152.txt : 20131108 0001225208-13-023152.hdr.sgml : 20131108 20131108141337 ACCESSION NUMBER: 0001225208-13-023152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131108 FILED AS OF DATE: 20131108 DATE AS OF CHANGE: 20131108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 425 METRO PLACE NORTH STREET 2: SUITE 300 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 425 METRO PLACE NORTH STREET 2: SUITE 300 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cope Frederick O CENTRAL INDEX KEY: 0001456549 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 131203961 MAIL ADDRESS: STREET 1: 425 METRO PLACE NORTH CITY: DUBLIN STATE: OH ZIP: 43017 4 1 doc4.xml X0306 4 2013-11-08 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001456549 Cope Frederick O 425 METRO PLACE NORTH SUITE 450 DUBLIN OH 43017 1 SVP Common Stock 2013-11-08 4 P 0 3500.0000 1.4300 A 90814.0000 D Common Stock 8637.0000 I By 401(k) William J. Kelly, Jr., Attorney-In-Fact 2013-11-08